AMENDOLA, ANGELA
 Distribuzione geografica
Continente #
AS - Asia 129
NA - Nord America 122
EU - Europa 118
SA - Sud America 25
Continente sconosciuto - Info sul continente non disponibili 17
AF - Africa 5
Totale 416
Nazione #
US - Stati Uniti d'America 115
IT - Italia 79
SG - Singapore 38
HK - Hong Kong 31
BR - Brasile 21
CN - Cina 18
RU - Federazione Russa 13
VN - Vietnam 12
BD - Bangladesh 6
CA - Canada 6
DE - Germania 6
FR - Francia 6
IN - India 5
NL - Olanda 4
TR - Turchia 4
IE - Irlanda 3
TW - Taiwan 3
AR - Argentina 2
CI - Costa d'Avorio 2
FI - Finlandia 2
GB - Regno Unito 2
ID - Indonesia 2
JP - Giappone 2
PH - Filippine 2
PK - Pakistan 2
TH - Thailandia 2
TN - Tunisia 2
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
IQ - Iraq 1
JM - Giamaica 1
OM - Oman 1
PE - Perù 1
UA - Ucraina 1
Totale 399
Città #
San Jose 28
Ashburn 25
Singapore 19
Hong Kong 12
Milan 10
Beijing 9
New York 7
Los Angeles 6
Naples 6
Columbus 5
Council Bluffs 5
Alcamo 4
Palermo 4
Santa Clara 4
Boardman 3
Chennai 3
Dublin 3
Falkenstein 3
Florence 3
Ho Chi Minh City 3
Istanbul 3
Lauterbourg 3
São Paulo 3
Verona 3
Abidjan 2
Bengaluru 2
Bergamo 2
Bà Rịa 2
Chiang Mai 2
Fragagnano 2
Frankfurt am Main 2
Guangzhou 2
Helsinki 2
Houston 2
Itri 2
Moscow 2
Parma 2
Phoenix 2
Rome 2
Taipei 2
Toronto 2
Arraial do Cabo 1
Atlanta 1
Bari 1
Belford Roxo 1
Betim 1
Boca Raton 1
Bologna 1
Boston 1
Brazzaville 1
Buenos Aires 1
Buffalo 1
Bunker Hill 1
Buriti Bravo 1
Calgary 1
Campinas 1
Can Tho 1
Canoas 1
City of Muntinlupa 1
Da Nang 1
Daireaux 1
Denver 1
Edmond 1
Elk Grove 1
Faisalabad 1
Florianópolis 1
Fuzhou 1
Gordon 1
Groningen 1
Haiphong 1
Hanoi 1
Hải Dương 1
Ilhéus 1
Ipatinga 1
Itapecerica da Serra 1
Jaboticabal 1
Jacksonville 1
Jakarta 1
Jandira 1
Kansas City 1
Lahore 1
Lima 1
Lombard 1
Manchester 1
Manila 1
Marechal Cândido Rondon 1
Menzel Temime 1
Miano 1
Minneapolis 1
Montreal 1
Muscat 1
New Taipei 1
Novo Hamburgo 1
Nuremberg 1
Obata 1
Ottawa 1
Padua 1
Paris 1
Paty do Alferes 1
Ponorogo 1
Totale 267
Nome #
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 209
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials 72
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials 71
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 46
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patients 8
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab‐Refractory Multiple Myeloma Patients: A Multicenter Real‐World Study 5
Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data 5
Totale 416
Categoria #
all - tutte 1.392
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.392


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202472 3 5 19 0 8 7 21 2 0 0 4 3
2024/2025100 7 3 4 7 2 9 13 9 2 2 15 27
2025/2026203 26 4 16 14 19 8 20 12 26 27 7 24
2026/202741 22 16 3 0 0 0 0 0 0 0 0 0
Totale 416